+44(0)208 9952500 karen.stancombe@lionsdencommunications.com LionsDen Communications Lionsden medical John Clare

Blog

50 years of cancer change?

I’m in Chicago for the 50th anniversary congress of ASCO, the American Society of Clinical Oncology.  Sitting in one of the sessions I found myself wondering how much cancer treatment has improved in that time, and how far has life expectancy been extended. Sadly I couldn’t find the answer either in the #ASCO14 website, or any of the congress material. Surely someone has done a historical piece? #cancerdrug.

The Pfizer bid for AZ

The Pfizer bid for AZ  be over, as least for now. However the ramifications are huge, particularly for both CEOs. Soriot will now be under great pressure from investors to deliver the new drugs he promised, and get the share price close to the £55 offered by Pfizer asap. For Read it’s a humiliating and public slap in the face. How did he get it so wrong? And what will be the US consequences of announcing he wants to move to Europe to keep the Pfizer cash pile out of the hands of the IRS?  Much more action to come, methinks.

http://www.in-pharmatechnologist.com/Processing/AstraZeneca-once-again-rejects-sweetened-Pfizer-takeover-bid

Prof David White. Ontario.

‘A must-read for all doctors and scientists involved in presenting results of medical research.’